WisconsinRelating to: utilization management controls for antipsychotic prescription drugs under the Medical Assistance program. (FE)
What it does
Plain-language analysis is being updated.
Use the official record and source text while enrichment finishes.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed Senate
- Passed House
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Mar 23Failed to pass pursuant to Senate Joint Resolution 1Latest
- 2025
- Nov 12Available for scheduling
- Vote recorded Report passage as amended recommended by Committee on Mental Health, Substance Abuse Prevention, Children and Families, Ayes 3, Noes 2. Result: pass.Upper
- Vote recorded Report adoption of Senate Substitute Amendment 2 recommended by Committee on Mental Health, Substance Abuse Prevention, Children and Families, Ayes 3, Noes 2. Result: pass.Upper
- Nov 12Report passage as amended recommended by Committee on Mental Health, Substance Abuse Prevention, Children and Families, Ayes 3, Noes 2Minor
- Nov 12Report adoption of Senate Substitute Amendment 2 recommended by Committee on Mental Health, Substance Abuse Prevention, Children and Families, Ayes 3, Noes 2Major
- Nov 12Executive action taken
- Nov 6Public hearing held
- Oct 3Senate Substitute Amendment 2 offered by Senator JamesMinor
- Sep 9Representative Subeck added as a cosponsor
- May 16Senate Substitute Amendment 1 offered by Senator JamesMinor
- Mar 27Fiscal estimate receivedMinor
- Feb 26Read first time and referred to Committee on Mental Health, Substance Abuse Prevention, Children and FamiliesMinor
- Feb 26Introduced by Senators James, Cabral-Guevara and Wanggaard; cosponsored by Representatives Novak, Gundrum, B. Jacobson, Mursau, Sortwell, Steffen and TittlIntroduced
- Nov 12Available for scheduling